Patents Assigned to Broteio Pharma B.V.
  • Binding molecules that bind human complement factor C2 and uses thereof
    Patent number: 10717785
    Abstract: The invention relates to means and methods that relate to binding molecules that bind human complement factor C2. Specific binding molecules are described with specific C2 activity inhibiting properties. Such binding molecules are useful in the treatment of symptoms of various human diseases among which there is inflammatory disease, neuro-inflammatory disease or ischemia-reperfusion (I/R) injury disease.
    Type: Grant
    Filed: February 23, 2018
    Date of Patent: July 21, 2020
    Assignee: BROTEIO PHARMA B.V.
    Inventors: Cornelis Erik Hack, Cafer Yildiz, Louis Boon, Petrus Johannes Simons
  • Binding molecules that bind human complement factor C2 and uses thereof
    Patent number: 9944717
    Abstract: The invention relates to means and methods that relate to binding molecules that bind human complement factor C2. Specific binding molecules are described with specific C2 activity inhibiting properties. Such binding molecules are useful in the treatment of symptoms of various human diseases among which there is inflammatory disease, neuro-inflammatory disease or ischemia-reperfusion (I/R) injury. Disease.
    Type: Grant
    Filed: May 22, 2014
    Date of Patent: April 17, 2018
    Assignee: Broteio Pharma B.V.
    Inventors: Cornelis Erik Hack, Cafer Yildiz, Louis Boon, Petrus Johannes Simons